Malaria

AB1_MALARIA

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

185

6. Filter based on genotype QC (FinnGen only)

185

Control definitions (FinnGen only)

Control exclude
AB1_PROTOZOAL

Extra metadata

First used in FinnGen datafreeze
DF5

Case counts by codes

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2110 834 1215
Only index persons 1820 733 1087
Unadjusted period prevalence (%)
Whole population 0.03 0.02 0.03
Only index persons 0.04 0.03 0.04
Median age at first event (years)
Whole population 35.94 35.12 36.67
Only index persons 35.61 34.39 36.42

-FinnGen-

Key figures

All Female Male
Number of individuals 185 89 96
Unadjusted period prevalence (%) 0.04 0.03 0.04
Median age at first event (years) 37.88 34.30 41.21

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
164
Matched controls
1640
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B50.9
ICD-10 Finland
Plasmodium falciparum malaria, unspecified
+∞
57.8
52
*
B54
ICD-10 Finland
Unspecified malaria
+∞
43.7
40
*
0840A
ICD-9 Finland
Malaria, Falciparum malaria [malignant tertian]
+∞
14.8
14
*
08410
ICD-8 Finland
Vivax malaria (benign tertian)
+∞
9.5
9
*
R50.9
ICD-10 Finland
Fever, unspecified
3.7
8.7
40
131
B50.0
ICD-10 Finland
Plasmodium falciparum malaria with cerebral complications
+∞
7.3
7
*
B51.9
ICD-10 Finland
Plasmodium vivax malaria without complication
+∞
7.3
7
*
08499
ICD-8 Finland
Malaria, Unspecified forms
+∞
6.3
6
*
B53.0
ICD-10 Finland
Plasmodium ovale malaria
+∞
6.3
6
*
08400
ICD-8 Finland
Falicparum malaria (malignant tertian)
+∞
6.3
6
*
0846X
ICD-9 Finland
Malaria, unspecified
+∞
6.3
6
*

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018095) Leukocytes [#/volume] in Urine
82
521
2.03
5.18
3.9
3.4
e6/l
17.3
116.5
1.21
59
370
(42870588) Differential panel, method unspecified - Blood
74
464
1.99
4.77
7.5
5.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
70
455
1.87
3.91
3.4
2.9
e6/l
12.2
54.7
1.95
58
350
(3026782) Osmolality of Urine
50
291
1.98
3.87
2.9
2.4
mosm/kgh2o
581.0
583.2
0.02
42
247
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
29
137
2.32
3.80
1.9
2.2
u/l
28.5
33.5
0.45
21
118
(36304419) Bacteria [Presence] in Urine
63
404
1.85
3.63
3.2
2.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
73
491
1.80
3.59
3.8
3.1
u/l
28.0
31.0
0.84
67
466
(3003694) ABO and Rh group [Type] in Blood
61
389
1.85
3.56
1.6
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
74
501
1.80
3.56
3.7
3.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
51
326
1.78
2.89
2.0
1.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
60
406
1.71
2.78
3.4
2.9
e6/l
0.3
0.5
0.45
48
304
(3000850) Epithelial cells [#/volume] in Urine
48
309
1.75
2.64
2.8
2.4
e6/l
4.9
6.7
0.25
43
279
(3007853) Bacteria identified in Skin by Aerobe culture
30
169
1.93
2.51
1.6
1.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
87
670
1.56
2.32
8.2
5.9
%
0.7
0.7
0.11
80
621
(3021879) Hepatitis B virus core Ab [Presence] in Serum
21
108
2.07
2.26
1.9
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
9
5.67
2.22
2.2
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
30
177
1.83
2.19
2.0
2.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
88
687
1.54
2.17
8.1
5.9
%
2.7
2.8
0.31
81
640
(3013115) Eosinophils [#/volume] in Blood
94
746
1.53
2.14
8.8
6.4
e9/l
0.2
0.2
0.76
81
670
(3019069) Monocytes/100 leukocytes in Blood
88
691
1.52
2.09
8.3
6.2
%
9.0
8.5
0.77
81
648
(3021589) Normoblasts [#/volume] in Blood
86
673
1.52
2.07
11.8
9.2
e9/l
0.0
0.0
0.52
70
551
(3002256) Pathology report gross observation
29
173
1.80
2.05
1.4
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
48
331
1.61
2.01
2.8
2.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
156
1398
1.74
2.01
17.8
13.1
%
40.4
40.5
0.08
115
1081
(3019198) Lymphocytes [#/volume] in Blood
93
744
1.50
1.99
8.1
6.1
e9/l
1.8
1.8
0.00
76
671
(3017143) Hepatitis C virus Ab [Presence] in Serum
29
175
1.78
1.97
2.2
1.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
91
728
1.49
1.93
8.2
6.1
e9/l
0.5
0.6
0.81
75
639
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
39
258
1.65
1.92
3.0
3.0
ng/l
719.5
124.3
0.60
26
185
(3006315) Basophils [#/volume] in Blood
91
729
1.49
1.92
8.2
6.1
e9/l
0.0
0.0
0.31
75
641
(3002030) Lymphocytes/100 leukocytes in Blood
89
710
1.49
1.91
8.2
6.0
%
30.4
27.6
1.38
82
665
(3019832) Treponema pallidum Ab [Presence] in Serum
28
170
1.76
1.87
1.8
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
31
195
1.71
1.84
2.7
2.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
87
696
1.47
1.82
7.9
5.8
%
55.2
57.5
0.87
80
652
(40768804) Tissue Pathology biopsy report
72
559
1.47
1.73
2.9
2.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
114
971
1.45
1.67
4.9
3.9
—
—
—
0
0
(4035726)
21
122
1.81
1.63
1.5
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
14
3.64
1.62
2.6
2.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
33
219
1.62
1.61
3.4
2.8
e6/l
2.2
2.0
0.06
19
113
(3000494) Fungus identified in Specimen by Culture
27
170
1.69
1.60
2.0
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
20
3.06
1.59
1.5
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
15
3.39
1.53
1.6
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
15
3.39
1.53
1.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
15
3.39
1.53
2.6
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
21
2.92
1.52
1.8
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
37
2.50
1.50
2.2
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
74
591
1.42
1.50
7.7
4.3
g/l
36.3
35.9
0.28
68
555
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
16
3.18
1.44
1.6
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
5
16
3.18
1.44
2.4
2.2
—
544.3
—
0
6
(3035637) Corticotropin [Mass/volume] in Plasma
5
16
3.18
1.44
1.6
1.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
53
401
1.45
1.43
1.7
1.6
mmol/l
1.3
1.4
1.28
44
338
(3003327) Ova and parasites identified in Stool by Light microscopy
10
46
2.24
1.42
2.5
1.7
—
—
—
0
0
(1002224) Polysomnography panel
13
67
2.01
1.42
1.0
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
51
385
1.45
1.39
9.4
6.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
17
2.99
1.36
1.2
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
17
2.99
1.36
1.2
1.9
—
—
—
0
0
(44806118)
5
17
2.99
1.36
3.0
1.6
—
—
—
0
0
(44790049)
5
17
2.99
1.36
3.0
1.6
—
—
—
0
0
(44790047)
5
17
2.99
1.36
3.0
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
17
2.99
1.36
1.2
1.9
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
17
2.99
1.36
2.6
1.8
—
—
—
0
0
(44790048)
5
17
2.99
1.36
3.0
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
19
114
1.74
1.34
3.8
4.9
%
1.0
0.4
—
7
31
(3022217) INR in Platelet poor plasma by Coagulation assay
24
154
1.64
1.34
26.3
18.6
inr
2.0
1.2
—
5
24
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
34
238
1.53
1.33
3.0
2.7
e6/l
0.6
0.9
0.41
19
131
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
24
2.55
1.31
2.0
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
10
188
0.51
1.29
1.4
1.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
9
44
2.10
1.29
1.9
1.6
%
92.1
94.0
—
9
44
(3044640) Blood type and Crossmatch panel - Blood
57
447
1.40
1.25
2.9
2.2
—
—
—
0
0
(4268621)
5
19
2.67
1.22
2.4
2.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
27
183
1.56
1.22
1.5
1.8
%
1.5
1.5
0.19
22
160
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
31
217
1.51
1.22
2.2
1.9
—
—
—
0
0
(3044889) 12 lead EKG panel
116
1023
1.36
1.20
3.6
3.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
50
386
1.40
1.20
4.7
4.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
57
1.99
1.19
3.1
2.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
26
2.35
1.19
2.3
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
100
864
1.34
1.17
12.4
9.6
e9/l
3.6
4.1
2.30
85
757
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
17
103
1.72
1.17
2.8
2.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
39
2.10
1.17
1.4
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
30
2.38
1.13
1.4
1.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
125
1123
1.35
1.10
11.4
7.5
u/l
74.1
75.7
0.23
117
1058
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
46
2.00
1.05
1.9
2.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
53
422
1.36
1.05
5.1
3.6
ph
7.4
7.4
—
8
83
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
151
1402
1.42
1.04
17.5
12.0
ml/min/173m2
82.3
84.4
0.51
124
1138
(3025130) Human papilloma virus identified in Specimen
5
22
2.31
1.04
1.8
1.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
22
2.31
1.04
1.0
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
5
22
2.31
1.04
9.8
3.0
u/ml
44.6
16.2
—
5
22
(3042936) Bacteria identified in Isolate by Culture
29
208
1.47
1.02
2.5
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
79
670
1.31
1.02
5.2
3.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
25
174
1.51
1.02
2.2
2.8
umol/l
5.6
9.0
1.15
20
148
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
14
84
1.72
1.01
2.4
1.9
—
—
—
0
0
(4306422)
5
23
2.21
0.98
1.2
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
36
1.98
0.98
1.0
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
36
1.98
0.98
1.4
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
41
317
1.38
0.97
2.8
1.9
mg/l
3.5
3.0
0.34
34
278
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
33
246
1.42
0.96
1.5
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
18
118
1.58
0.95
5.2
4.9
%
0.3
0.2
—
9
38
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
77
656
1.30
0.95
8.1
6.3
mmol/l
1.2
1.2
0.28
67
559
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
72
608
1.30
0.95
8.7
5.1
mmol/l
1.2
1.2
0.10
67
556
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
27
2.26
0.94
4.0
3.6
%
54.8
60.4
—
6
27
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
88
765
1.29
0.92
10.2
6.3
umol/l
10.2
10.8
0.48
82
733
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
28
2.18
0.92
1.2
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
113
1015
1.29
0.91
3.4
3.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
103
1.61
0.91
1.6
2.8
ml/min/173m2
68.8
66.7
—
5
44
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
62
516
1.30
0.90
2.1
1.9
pmol/l
97.2
95.1
0.15
31
261
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
29
2.10
0.90
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
29
2.10
0.90
1.2
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
42
1.94
0.90
1.6
2.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
11
64
1.76
0.88
1.4
1.2
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
6
30
2.03
0.87
2.2
2.2
kpa
5.0
4.9
—
6
30
(3027315) Oxygen [Partial pressure] in Blood
6
30
2.03
0.87
2.2
2.2
kpa
8.0
9.0
—
6
30
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
23
163
1.47
0.87
1.7
1.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
66
557
1.29
0.86
2.7
2.4
nmol/l
78.2
74.2
0.57
61
493
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
167
1596
1.48
0.80
13.4
9.7
u/l
25.1
27.2
1.08
160
1543
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
48
1.70
0.80
2.6
3.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
24
0.00
0.80
0.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
24
2.11
0.75
1.0
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
38
1.87
0.74
2.9
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
16
109
1.51
0.74
3.8
2.5
e9/l
90.7
70.5
—
10
81
(3001122) Ferritin [Mass/volume] in Serum or Plasma
72
625
1.25
0.73
3.5
2.7
ug/l
125.7
115.3
0.15
65
582
(3020564) Creatinine [Moles/volume] in Serum or Plasma
165
1579
1.42
0.72
20.6
14.9
umol/l
79.5
77.4
0.44
165
1579
(3045414) Leukocytes [Presence] in Urine
9
57
1.61
0.72
1.3
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
40
1.78
0.72
1.1
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
23
170
1.40
0.72
4.3
2.5
ug/g
165.3
100.5
0.69
14
135
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
5
26
1.95
0.71
1.2
1.2
—
1.7
—
0
10
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
21
153
1.42
0.71
2.0
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
41
1.73
0.70
1.1
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
15
103
1.50
0.67
1.6
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
18
129
1.44
0.66
5.2
4.7
%
1.0
1.0
—
9
44
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
44
1.61
0.66
1.0
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
12
79
1.55
0.64
13.0
5.0
mmol/l
25.3
24.8
0.25
12
79
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
21
157
1.38
0.62
2.2
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
156
1490
1.30
0.60
17.9
13.0
mg/l
24.1
23.6
0.05
121
1171
(3019309) Folate [Moles/volume] in Red Blood Cells
28
222
1.31
0.58
1.7
1.7
nmol/l
1025.4
1280.0
0.90
21
168
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
35
1.74
0.58
1.2
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
149
1418
1.26
0.57
3.9
3.8
mmol/l
1.2
1.3
1.22
135
1310
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
154
1472
1.28
0.56
4.5
4.2
mmol/l
4.6
4.7
0.31
144
1375
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
6
37
1.64
0.56
1.3
1.4
—
2.2
—
0
6
(3009261) Glucose [Presence] in Urine by Test strip
79
709
1.20
0.56
3.5
3.5
estimate
0.0
0.0
0.00
14
138
(40768793) Breast Pathology biopsy report
6
38
1.60
0.55
1.5
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
15
109
1.41
0.53
6.1
5.1
%
0.3
0.3
—
7
32
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
113
1052
1.19
0.52
3.3
3.0
u/l
46.2
47.8
0.08
102
994
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
31
374
0.79
0.52
3.4
2.9
ng/l
713.0
953.0
0.50
25
304
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
178
0.71
0.51
1.5
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
172
1672
1.41
0.51
25.3
18.9
g/l
134.0
136.8
1.59
172
1645
(3007164) IgA [Mass/volume] in Serum or Plasma
26
320
0.78
0.51
1.7
1.3
g/l
2.0
2.5
1.17
15
190
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
37
310
1.24
0.51
2.6
3.1
ug/l
0.7
0.8
0.45
31
196
(3000991) Gas panel - Venous blood
15
110
1.40
0.50
11.9
6.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
77
695
1.18
0.50
3.5
3.4
estimate
0.0
0.0
0.00
16
144
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
46
1.54
0.49
1.4
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
60
531
1.19
0.49
7.1
7.2
inr
1.1
1.2
1.99
21
166
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
48
1.48
0.47
1.7
1.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
13
94
1.41
0.47
4.9
2.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
77
700
1.17
0.45
4.9
4.7
estimate
0.0
0.0
0.00
16
146
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
141
1347
1.20
0.44
4.8
4.5
mu/l
1.9
1.9
0.13
127
1232
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
11
78
1.44
0.44
4.4
3.6
mmol/l
0.6
1.6
—
6
62
(3019150) Specific gravity of Urine by Refractometry
24
291
0.80
0.42
2.7
3.7
kg/l
1.0
1.0
—
5
36
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
32
270
1.22
0.42
2.3
1.7
pmol/l
482.7
468.9
0.10
27
236
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
59
1.37
0.41
7.0
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
17
0.00
0.41
0.0
2.5
—
13.5
—
0
17
(3022313) Gas panel - Capillary blood
8
60
1.35
0.41
3.6
3.7
—
—
—
0
0
(4010399)
7
102
0.67
0.41
1.9
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
7
102
0.67
0.41
4.1
3.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
47
414
1.18
0.40
4.0
4.4
%
19.4
20.6
0.26
26
195
(3029937) Albumin [Presence] in Urine by Test strip
44
386
1.18
0.39
3.7
3.6
estimate
0.0
0.0
0.50
15
138
(3011288) Drugs identified in Urine by Screen method
5
36
1.40
0.38
1.2
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
154
1491
1.20
0.36
4.8
4.6
mmol/l
2.8
2.8
0.11
146
1383
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
42
1.44
0.36
1.8
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
42
1.44
0.36
1.0
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
73
1.39
0.35
1.9
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
44
1.38
0.35
1.0
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
44
1.38
0.35
1.2
1.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
37
325
1.17
0.33
1.5
1.5
nmol/l
22.4
21.7
0.10
30
271
(36660697) Celiac disease serology panel - Serum
16
129
1.26
0.31
1.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
75
1.35
0.31
2.3
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
58
531
1.13
0.30
4.7
4.8
ug/l
2.5
2.6
0.08
52
474
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
50
548
0.88
0.29
3.7
3.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
8
63
1.28
0.28
15.8
6.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
18
150
1.22
0.27
4.3
3.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
40
360
1.14
0.27
3.4
2.6
umol/l
366.5
9495.5
2.16
31
316
(3008152) Bicarbonate [Moles/volume] in Arterial blood
5
75
0.66
0.26
17.4
7.3
mmol/l
24.5
23.8
—
5
70
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
73
1.24
0.26
1.3
1.3
—
—
—
0
0
(3000492) Spirometry study
19
161
1.20
0.25
1.5
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
147
0.80
0.24
4.7
6.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
146
1421
1.13
0.24
4.7
4.1
mmol/l
6.0
5.9
0.15
131
1302
(4094501)
5
37
1.36
0.23
1.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
15
125
1.22
0.23
6.4
3.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
39
1.29
0.23
1.4
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
41
1.23
0.22
1.6
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
41
1.23
0.22
1.6
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
41
1.23
0.22
1.4
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
41
1.23
0.22
1.6
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
42
1.20
0.21
1.4
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
11
0.00
0.21
0.0
3.0
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
0
10
0.00
0.21
0.0
1.3
—
3234.0
—
0
5
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
259.7
—
0
10
(3015183) Erythrocyte sedimentation rate
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
43
1.17
0.21
1.4
1.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
5
43
1.17
0.21
11.2
4.4
—
3.5
—
0
7
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
43
1.17
0.21
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
123
0.80
0.21
1.1
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
150
1466
1.12
0.21
4.4
4.2
mmol/l
1.4
1.4
0.18
138
1362
(3011648) Oxygen content in Venous blood
0
13
0.00
0.21
0.0
1.9
—
12.2
—
0
13
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
2.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
175
0.84
0.19
1.3
1.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
52
1.16
0.19
1.3
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
81
1.25
0.19
1.4
1.2
—
—
—
0
0
(3012544) pH of Venous blood
15
129
1.18
0.17
3.1
3.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
67
0.74
0.17
1.2
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
68
0.73
0.17
1.2
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
68
0.73
0.17
1.2
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
35
322
1.11
0.17
3.3
3.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
56
529
1.08
0.16
3.5
3.5
ng/l
53.6
38.7
0.19
40
345
(3025941) Bacteria identified in Stool by Culture
10
83
1.22
0.16
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
80
0.74
0.15
1.0
1.0
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
16
140
1.16
0.15
12.7
6.2
kpa
5.1
5.0
0.03
16
135
(3027801) Oxygen [Partial pressure] in Arterial blood
16
140
1.16
0.15
12.7
6.2
kpa
13.7
12.8
0.29
16
135
(40768797) Stomach Pathology biopsy report
17
192
0.87
0.15
1.5
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
9
79
1.15
0.15
5.9
4.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
40
374
1.09
0.14
4.8
3.2
mg/l
118.6
220.0
0.25
28
259
(3020682) Albumin/Creatinine [Ratio] in Urine
42
394
1.09
0.14
6.7
3.9
mg/mmol
21.1
10.2
0.34
26
268
(3013512) EKG study
39
365
1.09
0.14
3.8
3.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
14
158
0.88
0.12
4.9
4.3
%
33.8
31.3
—
9
105
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
138
1355
1.07
0.12
6.3
5.2
mmol/mol
39.0
39.6
0.35
130
1276
(3022145) Colonoscopy Study observation
15
168
0.88
0.12
1.8
1.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
11
126
0.86
0.11
17.5
6.4
%
97.8
96.0
1.46
11
121
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
22
238
0.91
0.10
1.2
1.3
u/ml
1.0
9.5
—
5
92
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
47
1.07
0.09
1.4
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
47
1.07
0.09
1.4
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
48
1.04
0.09
1.4
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
48
1.04
0.09
1.4
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
59
611
0.95
0.09
3.6
2.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
6
57
1.05
0.08
1.8
1.6
mg/l
31.4
4.0
—
6
35
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
70
0.85
0.08
3.7
2.3
%
1.1
1.2
—
6
70
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
111
1091
1.04
0.07
4.4
3.9
pmol/l
14.3
14.7
1.00
97
1004
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
11
99
1.12
0.06
1.1
1.2
—
54.8
—
0
7
(40760892) CBC W Ordered Manual Differential panel - Blood
36
346
1.05
0.06
5.8
5.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
11
100
1.11
0.05
3.5
4.1
ng/l
100.4
81.7
0.17
11
89
(3009508) Creatinine [Moles/volume] in Urine
42
408
1.04
0.04
4.7
3.0
mmol/l
7.2
8.1
0.69
35
341
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
30
290
1.04
0.03
1.5
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
92
1.09
0.03
1.8
2.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
26
251
1.04
0.03
1.3
1.2
iu/ml
38.0
31.1
—
7
85
(3041096) Erythrocytes [Presence] in Urine by Automated
41
403
1.02
0.01
3.6
2.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
23
233
0.99
0.00
1.4
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
158
1575
1.02
0.00
14.4
11.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
40
395
1.02
0.00
2.7
2.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
109
1093
0.99
0.00
4.5
3.8
mm/h
10.8
11.0
0.05
103
1010
(3019225) pH of Specimen
11
108
1.02
0.00
6.1
5.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
10
105
0.95
0.00
1.6
2.4
ug/l
12.0
8.3
—
10
96
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
5
0.00
0.00
0.0
4.6
—
52.0
—
0
5
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
5
0.00
0.00
0.0
2.0
—
0.8
—
0
5
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
67
0.89
0.00
4.5
2.9
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
83
0.96
0.00
1.3
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
11.0
—
0
6
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
7
0.00
0.00
0.0
1.4
—
26.8
—
0
7
(3017704) Immunofixation for Urine
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(4133840)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
104.4
—
0
9
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
8.3
—
0
7
(3004451) EKG impression Narrative
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint AB1_MALARIA and mortality.

Females

Parameter HR [95% CI] p-value
AB1_MALARIA 2.107 [1.54, 2.88] < 0.001
Birth year 1.002 [0.99, 1.01] 0.702

During the follow-up period (1.1.1998 — 31.12.2019), 94 out of 611 females with AB1_MALARIA died.

Males

Parameter HR [95% CI] p-value
AB1_MALARIA 1.356 [1.05, 1.74] 0.018
Birth year 0.987 [0.98, 1.0] 0.007

During the follow-up period (1.1.1998 — 31.12.2019), 85 out of 823 males with AB1_MALARIA died.

Mortality risk

Mortality risk for people of age

years, who have AB1_MALARIA.

N-year risk Females Males
1 0.239% 0.241%
5 1.427% 1.494%
10 3.723% 3.803%
15 7.009% 7.091%
20 12.556% 12.263%

Relationships between endpoints

Index endpoint: AB1_MALARIA – Malaria

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data